Kopala L - Search Results

1

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders.

Kutcher S, Brooks SJ, Gardner DM, Honer B, Kopala L, Labelle A, Lalonde P, Malla A, Milliken H, Soni J, Williams R. Kutcher S, et al. Among authors: kopala l. Neuropsychiatr Dis Treat. 2005 Jun;1(2):89-108. doi: 10.2147/nedt.1.2.89.61042. Neuropsychiatr Dis Treat. 2005. PMID: 18568067 Free PMC article.

2

Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders.

Kopala L, Smith G, Malla A, Williams R, Love L, Talling D, Balshaw R. Kopala L, et al. Acta Psychiatr Scand Suppl. 2006;(430):29-39. doi: 10.1111/j.1600-0447.2006.00759.x. Acta Psychiatr Scand Suppl. 2006. PMID: 16542323 Clinical Trial.

3

Sex differences in olfactory function in young patients with psychotic disorders.

Good KP, Leslie RA, McGlone J, Milliken HI, Kopala LC. Good KP, et al. Schizophr Res. 2007 Dec;97(1-3):97-102. doi: 10.1016/j.schres.2007.07.009. Epub 2007 Aug 16. Schizophr Res. 2007. PMID: 17707121

4

First episode psychosis: early intervention strategies with second-generation antipsychotic medications.

Bryden KE, Gardner DM, Kopala LC. Bryden KE, et al. Among authors: kopala lc. Int J Clin Pract. 2003 Jul-Aug;57(6):513-8. Int J Clin Pract. 2003. PMID: 12918891 Review.

5

Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia.

Williams R, Kopala L, Malla A, Smith G, Love L, Balshaw R. Williams R, et al. Among authors: kopala l. Acta Psychiatr Scand Suppl. 2006;(430):12-21. doi: 10.1111/j.1600-0447.2006.00757.x. Acta Psychiatr Scand Suppl. 2006. PMID: 16542321

6

Unirhinal olfactory identification deficits in young male patients with schizophrenia and related disorders: association with impaired memory function.

Good KP, Martzke JS, Milliken HI, Honer WG, Kopala LC. Good KP, et al. Schizophr Res. 2002 Aug 1;56(3):211-23. doi: 10.1016/s0920-9964(01)00227-4. Schizophr Res. 2002. PMID: 12072170

7

The Canadian National Outcomes Measurement Study in Schizophrenia: overview of the patient sample and methodology.

Smith G, Malla A, Williams R, Kopala L, Love L, Balshaw R. Smith G, et al. Among authors: kopala l. Acta Psychiatr Scand Suppl. 2006;(430):4-11. doi: 10.1111/j.1600-0447.2006.00756.x. Acta Psychiatr Scand Suppl. 2006. PMID: 16542320

8

Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders.

Malla A, Williams R, Kopala L, Smith G, Talling D, Balshaw R. Malla A, et al. Among authors: kopala l. Acta Psychiatr Scand Suppl. 2006;(430):22-8. doi: 10.1111/j.1600-0447.2006.00758.x. Acta Psychiatr Scand Suppl. 2006. PMID: 16542322

9

Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes.

Kopala LC, Good KP, Milliken H, Buiteman C, Woodley H, Rui Q, Whitehorn D, Love L, Balshaw R, Kiss I, Honer WG. Kopala LC, et al. Schizophr Res. 2006 Jan 1;81(1):29-39. doi: 10.1016/j.schres.2005.09.009. Epub 2005 Nov 2. Schizophr Res. 2006. PMID: 16263246 Clinical Trial.

10

Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms.

Good KP, Whitehorn D, Rui Q, Milliken H, Kopala LC. Good KP, et al. Am J Psychiatry. 2006 May;163(5):932-3. doi: 10.1176/ajp.2006.163.5.932. Am J Psychiatry. 2006. PMID: 16648339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters